Lost password ?
<< Back to Equity Research
Dallah Healthcare
ROBUST, WAITING FOR A CORRECTION
Mar 11 - We have left Dallah Healthcare (Sell, Saudi Arabia) on a correction mode in our last short paper (08/2023) and we have welcomed the slide in a hope to open even a little buying window and take a ...
Executive summary
Conflict of Interest
Pages 38
Language English
Publish on March 11, 2024
€ 500
VAT Exl.
You might be also interested by these reports :
Apr 08 AM
Mouwasat Medical
Target pushed up by strong results
Mar 26 AM
Dallah Healthcare
Target boosted by a strong outlook
Mar 26 AM
Mouwasat Medical
Mouwasat Medical increases its net profit by 10%
Mar 15 AM
Dallah Healthcare
A slightly-weaker-than-expected Q4
FIND A REPORT
CONCEPT
Each company is researched in depth using a structured robust and transparent process.

AlphaMena provides analyses based upon exhaustive and homogeneous information which allows to compare stocks geographically, sector-wise, and by thematic.

The analyses include actuarial as well as off balance-sheet data.
BloombergStarmineFactsetReutersCapital IQ